JP2024513816A - インスリン産生及び分泌を改善するための方法ならびに組成物 - Google Patents

インスリン産生及び分泌を改善するための方法ならびに組成物 Download PDF

Info

Publication number
JP2024513816A
JP2024513816A JP2023560214A JP2023560214A JP2024513816A JP 2024513816 A JP2024513816 A JP 2024513816A JP 2023560214 A JP2023560214 A JP 2023560214A JP 2023560214 A JP2023560214 A JP 2023560214A JP 2024513816 A JP2024513816 A JP 2024513816A
Authority
JP
Japan
Prior art keywords
protein
oil
hmb
nutritional composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023560214A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513816A5 (enExample
Inventor
ペドロサ，ホセ マリア ロペス
カブレラ，リカルド ルエダ
マンザノ，マニュエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2024513816A publication Critical patent/JP2024513816A/ja
Publication of JP2024513816A5 publication Critical patent/JP2024513816A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2023560214A 2021-03-31 2022-03-31 インスリン産生及び分泌を改善するための方法ならびに組成物 Pending JP2024513816A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21382265 2021-03-31
EP21382265.3 2021-03-31
PCT/US2022/022712 WO2022212621A1 (en) 2021-03-31 2022-03-31 Methods and compositions for improving insulin production and secretion

Publications (2)

Publication Number Publication Date
JP2024513816A true JP2024513816A (ja) 2024-03-27
JP2024513816A5 JP2024513816A5 (enExample) 2025-04-07

Family

ID=75529926

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023560214A Pending JP2024513816A (ja) 2021-03-31 2022-03-31 インスリン産生及び分泌を改善するための方法ならびに組成物

Country Status (6)

Country Link
US (1) US20240065997A1 (enExample)
EP (1) EP4312594A1 (enExample)
JP (1) JP2024513816A (enExample)
CA (1) CA3213326A1 (enExample)
MX (1) MX2023011382A (enExample)
WO (1) WO2022212621A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023183767A1 (en) * 2022-03-21 2023-09-28 Abbott Laboratories Methods and compositions for increasing insulin sensitivity

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5714530A (en) * 1980-06-30 1982-01-25 Baldacci Lab Spa Pharmaceutic composition useful for treatment and diagnosis and feed regulant
JPS61215323A (ja) * 1985-03-20 1986-09-25 Otsuka Pharmaceut Co Ltd 栄養補給飲食品
JP2003511094A (ja) * 1999-10-18 2003-03-25 マッスルテク リサーチ アンド ディヴェロプメント インコーポレーション 無脂肪体重及び体力を増強するための食物補充物質
CA2746420A1 (en) * 2008-12-09 2010-06-17 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
WO2013148685A1 (en) * 2012-03-26 2013-10-03 Abbott Laboratories Pea protein containing nutritional compositions
JP2016513701A (ja) * 2013-03-14 2016-05-16 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 長期身体不活動に関連するインスリン抵抗性の治療
CN109090454A (zh) * 2018-08-07 2018-12-28 广西弘山堂生物科技有限公司 一种猴菇养胃粉及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4534579B2 (ja) * 2004-04-28 2010-09-01 味の素株式会社 リジン含有抗肥満または抗高脂血症用食品、飼料またはサプリメント

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5714530A (en) * 1980-06-30 1982-01-25 Baldacci Lab Spa Pharmaceutic composition useful for treatment and diagnosis and feed regulant
JPS61215323A (ja) * 1985-03-20 1986-09-25 Otsuka Pharmaceut Co Ltd 栄養補給飲食品
JP2003511094A (ja) * 1999-10-18 2003-03-25 マッスルテク リサーチ アンド ディヴェロプメント インコーポレーション 無脂肪体重及び体力を増強するための食物補充物質
CA2746420A1 (en) * 2008-12-09 2010-06-17 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
WO2013148685A1 (en) * 2012-03-26 2013-10-03 Abbott Laboratories Pea protein containing nutritional compositions
JP2016513701A (ja) * 2013-03-14 2016-05-16 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 長期身体不活動に関連するインスリン抵抗性の治療
CN109090454A (zh) * 2018-08-07 2018-12-28 广西弘山堂生物科技有限公司 一种猴菇养胃粉及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FLAKOLL, PAUL ET AL.: ""Effect of β-Hydroxy-β-Methylbutyrate, Arginine, and Lysine Supplementation on Strength, Function", NUTRITION, vol. 20, no. 5, JPN6026005863, May 2004 (2004-05-01), pages 445 - 451, ISSN: 0005797098 *

Also Published As

Publication number Publication date
US20240065997A1 (en) 2024-02-29
WO2022212621A1 (en) 2022-10-06
CA3213326A1 (en) 2022-10-06
MX2023011382A (es) 2023-10-06
EP4312594A1 (en) 2024-02-07

Similar Documents

Publication Publication Date Title
JP5830030B2 (ja) 筋タンパク質合成を刺激するための低カロリー高タンパク質栄養組成物
CN101626696B (zh) 包含糖寡聚物的营养产品
US20060159746A1 (en) Compositions comprising fatty acids and amino acids
EP1832179B1 (en) Carbohydrate composition and flat glucose response
JP2011509293A (ja) 老人の筋肉量、強度及び機能的能力を増加させる組成物及び方法
US11141397B2 (en) Composition for improving efficacy of L-DOPA treatment
CN105358144B (zh) 包括给予二十二碳六烯酸和α-硫辛酸的组合的用于促进神经元发育和/或健康的方法
TW201625144A (zh) 用於胃腸環境以提供改善之微生物群和代謝輪廓之營養組成物
US20100179089A1 (en) Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly
US20240065997A1 (en) Methods and Compositions for Improving Insulin Production and Secretion
US9345727B2 (en) Nutritional compositions containing a peptide component and uses thereof
US10086019B1 (en) Method to reduce insulin resistance and improve glucose tolerance using Parabacteroides goldsteinii
US20230112641A1 (en) Methods of treating diarrhea or inflammatory conditions of the gut
US20250205291A1 (en) Methods and compositions for slowing diabetes development of reducing a risk of diabetes
JP2023536157A (ja) 脂肪肝疾患を予防、低減または遅延させる方法
WO2023183767A1 (en) Methods and compositions for increasing insulin sensitivity
EP2777403A1 (en) Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring
US20230293561A1 (en) Method of preventing, reducing or delaying fatty liver disease
HK1221658B (en) Methods for promoting neuronal development and/or health comprising administration of a combination of docosahexaenoic acid and alpha-lipoic acid

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20231002

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20231004

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250328

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250328

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260518

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260804